Neurofibromatous changes in dermatofibrosarcoma protuberans: A potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm

Journal of Cutaneous Pathology

Volumn 31, Issue 7, 2004, Pages 492-496

  Kovarik, Carrie L ^a   Hsu, Mei Yu ^b   Cockerell, Clay J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; PROTEIN S 100;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; DERMATOFIBROSARCOMA PROTUBERANS; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROFIBROMATOSIS; SKIN DEFECT; SOFT TISSUE TUMOR; SPINDLE CELL; SUBCUTANEOUS TISSUE;

ADULT; AGED; AGED, 80 AND OVER; DERMATOFIBROSARCOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS;

EID: 3242756955     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2004.00212.x     Document Type: Article

References (13)

1. Gloster HM Jr. Dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996; 35: 355.
2. Haycox CL, Odland PB, Olbricht SM, Piepkorn M. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment. J Am Acad Dermatol 1997; 37: 438.
3. Koh CK, Ko CB, Bury HP, Wyatt EH. Dermatofibrosarcoma protuberans. Int J Dermatol 1995; 34: 256.
4. Bendix-Hansen K, Myhre-Jensen O, Kaae S. Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature. Scand J Plast Reconstr Surg 1983; 17:247.
5. Chuang TY, Su WP, Muller SA. Incidence of cutaneous T cell lymphoma and other rare skin cancers in a defined population. J Am Acad Dermatol 1990; 23: 254.
6. Lauritz BV, Mason GH. Dermatofibrosarcoma protuberans: an early non-protuberant phase of the tumour. Australas J Dermatol 1999; 40: 35.
7. Chuan MT, Tsai TF, Wu MC, Wong TH. Atrophic pigmented dermatofibrosarcoma presenting as infraorbital hyperpigmentation. Dermatology 1997; 194: 65.
8. Gutierrez G, Ospina JE, de Baez NE, de Escorcia EK, Gutierrez R. Dermatofibrosarcoma protuberans. Int J Dermatol 1984; 23: 396.
9. Oliveira-Soares R, Viana I, Vale E, Soares-Almeida LM, Picoto A. A clinicopathologic study of 20 cases. J Eur Acad Dermatol Venereol 2002; 16: 441.
10. Hsi ED, Nickoloff BJ. Dermatofibroma and dermatofibrosarcoma protuberans: an immunohistochemical study reveals distinctive antigenic profiles. J Dermatol Sci 1996; 11: 1.
11. Weiss SW, Nickoloff BJ. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions. AmJ Surg Pathol 1993; 17: 1039.
12. Aiba S, Tabata N, Ishii H, Ootani H, Tagami H. Dermatofibrosarcoma protuberans is a unique fibrohistiocytictumour expressing CD34. Br J Dermatol 1992; 127: 79.
13. Llatjos R, Fernandez-Figueras MT, Diaz-Cascajo C, Ribera M, Ariza A. Palisading and verocay body-prominent dermatofibrosarcoma protuberans: a report of three cases. Histopathology 2000; 37: 452.